Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-14T04:20:29.167Z Has data issue: false hasContentIssue false
  • English
  • Français

Sero-epidemiology of rubella in the urban population of Addis Ababa, Ethiopia

Published online by Cambridge University Press:  01 June 2000

F. T. CUTTS ,
A. ABEBE ,
T. MESSELE ,
A. DEJENE ,
F. ENQUSELASSIE ,
W. NIGATU  and
D. J. NOKES
F. T. CUTTS
Affiliation:
Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT, UK
A. ABEBE
Affiliation:
Ethiopian Health and Nutrition Research Institute, PO Box 1242, Addis Ababa, Ethiopia
T. MESSELE
Affiliation:
Ethiopian Health and Nutrition Research Institute, PO Box 1242, Addis Ababa, Ethiopia
A. DEJENE
Affiliation:
Ethiopian Health and Nutrition Research Institute, PO Box 1242, Addis Ababa, Ethiopia
F. ENQUSELASSIE
Affiliation:
Department of Community Health, Faculty of Medicine, University of Addis Ababa, PO Box 1176, Addis Ababa, Ethiopia Ecology and Epidemiology Group, Department of Biological Sciences, University of Warwick, Coventry, CV4 7AL, UK
W. NIGATU
Affiliation:
Ethiopian Health and Nutrition Research Institute, PO Box 1242, Addis Ababa, Ethiopia
D. J. NOKES
Affiliation:
Ecology and Epidemiology Group, Department of Biological Sciences, University of Warwick, Coventry, CV4 7AL, UK
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

We conducted a community-based cluster sample survey of rubella sero-epidemiology in Addis Ababa, Ethiopia in 1994. Among 4666 individuals for whom complete data were available, rubella antibody prevalence was 91% (95% confidence interval: 90, 92). On multivariable analysis, seroprevalence was lower among individuals who were resident in Addis Ababa for 1 year or less. Approx. 50% seroprevalence was attained by age 4 years, and the estimated average age at infection was 5·2 years. The highest age-specific force of infection was estimated to occur in 5- to 9-year-olds. The early age at infection corresponded with a low estimated incidence of congenital rubella syndrome (CRS) of 0·3 per 1000 live births, equivalent to nine cases of CRS in 1994. The predicted critical level of immunity for elimination of rubella via vaccination was 85–91%, requiring 89–96% coverage with a vaccine of 95% effectiveness. Unless very high coverage of rubella vaccine could be guaranteed, the introduction of childhood vaccination could increase the incidence of CRS in Addis Ababa.

Type
Research Article
Information
Epidemiology & Infection , Volume 124 , Issue 3 , June 2000 , pp. 467 - 479
Copyright
© 2000 Cambridge University Press